Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Junqueira, Daniela R G ^a   Perini, Edson ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; LOW MOLECULAR WEIGHT HEPARIN; THROMBOCYTE FACTOR 4;

ARTERIOGRAPHY; BINDING AFFINITY; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DRUG EXPOSURE; ECHOGRAPHY; ELECTROCARDIOGRAPHY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURGICAL PATIENT; SYSTEMATIC REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

EID: 70249130820     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007557     Document Type: Review

References (12)

1. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3):311S-37S. (Pubitemid 39297959)
2. Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia. Chest 2008;133 (Suppl 6):340S-80S.
3. Bircher AJ, Harr T, Hohenstein L, Tsakiris DA. Hypersensitivity reactions to anticoagulant drugs: diagnosis andmanagement options. Allergy 2006;61(12):1432-1440 (Pubitemid 44665308)
4. Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thrombosis Research 2006;118(2):165-176 (Pubitemid 43816669)
5. Kelton JG.Heparin-induced thrombocytopenia: an overview. Blood Reviews 2002;16(1):77-80.
6. Leo A, Winteroll S. Laboratoy diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants (Minireview). Clinical and Diagnostic Laboratory Immunology 2003; 10(5):731-740 (Pubitemid 37129479)
7. Manríquez JJ. A highly sensitive search strategy for clinical trials in Literatura Latino Americana e do Caribe em Ciências da Saúde (LILACS) was developed. Journal of Clinical Epidemiology 2008;61 (4):407-411
8. Cochrane Review Group on Peripheral Vascular Diseases. Resources for review authors [homepage internet]. http://pvd.cochrane.org/en/authors.htm.
9. Rice L. Cases of heparin-induced thrombocytopenia elucidate the syndrome. Chest 2005;127(2 Suppl):21S-6S. (Pubitemid 40224078)
10. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparininduced thrombocytopenia. Blood 2000;96(5):1703-1708 (Pubitemid 30661052)
11. Warkentin TE. Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia: recommendations of the College of American Pathologists. Archives of Pathology and Laboratory Medicine 2002;126(11):1415- 1423
12. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. British Journal of Haematology 2003;121(4):535-555